Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KNC Laboratories Co Ltd stock PB Ratio (=0.73) is close to 2-year high of 0.78.
The historical rank and industry rank for KNC Laboratories Co's PB Ratio or its related term are showing as below:
FRA:7LW'
s PB Ratio Range Over the Past 10 Years
Min: 0.56 Med: 0.96 Max: 7.95
Current: 0.72
During the past 11 years, KNC Laboratories Co's highest PB Ratio was 7.95. The lowest was 0.56. And the median was 0.96.
FRA:7LW's PB Ratio is ranked better than 82.99% of 1576
companies
in the Chemicals industry
Industry Median: 1.67
vs FRA:7LW: 0.72
During the past 12 months, KNC Laboratories Co's average Book Value Per Share Growth Rate was 4.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 6.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 7.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 12.60% per year.
During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of KNC Laboratories Co was 36.10% per year. The lowest was 3.50% per year. And the median was 7.55% per year.
Back to Basics: PB Ratio
KNC Laboratories Co (FRA:7LW) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
KNC Laboratories Co PB Ratio Related Terms
KNC Laboratories Co PB Ratio Historical Data
* Premium members only.
The historical data trend for KNC Laboratories Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, KNC Laboratories Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KNC Laboratories Co PB Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, KNC Laboratories Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where KNC Laboratories Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
KNC Laboratories Co (FRA:7LW) has a PB Ratio of 0.64 as of Jul. 17, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on KNC Laboratories Co and its competitors. This is 33% below median its historical median of 0.96. Over the past decade, KNC Laboratories Co's PB Ratio has ranged from 0.56 to 7.95. According to the industry distribution chart, KNC Laboratories Co ranks #268 out of 1576 companies in the Chemicals industry, placing it in the top 17%.
Is KNC Laboratories Co's PB Ratio too high?
KNC Laboratories Co's current PB Ratio of 0.64 is 33% below median its 10-year median of 0.96. Over the past 10 years, this metric has ranged from a low of 0.56 to a high of 7.95. The Chemicals industry median PB Ratio is 1.67. KNC Laboratories Co's value of 0.64 is 61.7% below this industry median. Based on the distribution chart, KNC Laboratories Co ranks #268 out of 1576 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, KNC Laboratories Co has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does KNC Laboratories Co's PB Ratio compare to DOW?
According to the Chemicals industry distribution chart, KNC Laboratories Co ranks #268 out of 1576 companies for PB Ratio. This places KNC Laboratories Co in the top 17% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.67. KNC Laboratories Co's value of 0.64 is 61.7% below this benchmark. Historically, KNC Laboratories Co's own PB Ratio has ranged from 0.56 to 7.95 over the past decade. While the company's 10-year median is 0.96 vs. the industry median of 1.67, KNC Laboratories Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Chemicals company?
The median PB Ratio among Chemicals companies is 1.67, based on 1,576 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KNC Laboratories Co's current PB Ratio of 0.64 is 61.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on KNC Laboratories Co and its competitors. For the Chemicals industry, the median PB Ratio is 1.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KNC Laboratories Co's current PB Ratio is 0.64, which is 33% below median its own 10-year median of 0.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KNC Laboratories Co stock overvalued right now?
KNC Laboratories Co (FRA:7LW) has a current PB Ratio of 0.64. The stock's GF Value™ is €6.31, compared to a current price of €6.30 — trading 0.2% below its estimated fair value. The current PB Ratio is 0.64, which is 33% below median its 10-year median of 0.96 and 61.7% below the Chemicals industry median of 1.67. KNC Laboratories Co's overall GF Score™ is 81/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For KNC Laboratories Co (FRA:7LW), the current PB Ratio is 0.64 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KNC Laboratories Co (FRA:7LW) Overvalued in 2026?
Based on GuruFocus' analysis, KNC Laboratories Co stock appears to be undervalued.
The current stock price of €6.30 is trading 0.2% below its estimated GF Value™ of €6.31.
Key valuation signals for FRA:7LW:
PB Ratio: 0.64 (33% below median its 10-year median of 0.96)
GF Value™: €6.31 vs. price of €6.30 (0.2% below fair value)
Industry Position: 61.7% below the Chemicals median (#268 of 1576)
No single metric tells the full story. See the FRA:7LW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7LW has been successfully added to your 
